STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 () to Promote Colon Cancer Progression.

Background: High expression of inhibitor of DNA binding 1 () correlates with poor prognosis in colorectal cancer (CRC). Aberrant enhancer activation in regulating transcription is limited.

Methods: Immunohistochemistry (IHC), quantitative RT-PCR (RT-qPCR) and Western blotting (WB) were used to determine the expression of .